| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8271968 | Journal of Geriatric Oncology | 2018 | 6 Pages |
Abstract
In patients who received neoadjuvant chemotherapy, there was a significant decrease in TPAI and HU during treatment. Prospective studies are warranted to assess the impact of TPAI loss and HU changes on clinical outcomes to better individualize treatment pathways based on a patient's fitness.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Andrew J. Benjamin, Mary M. Buschmann, Shuang Qin Zhang, Kristen Wroblewski, Hedy L. Kindler, Kevin K. Roggin, William Dale,